FDA inspection
Innoveix Pharmaceuticals Inc: FDA inspection ending May 27, 2021
FDA inspection 1142653 · Official Action Indicated (OAI) · Addison, TX
Key facts
| Inspection ID | 1142653 |
|---|---|
| Firm | Innoveix Pharmaceuticals Inc |
| FEI number | 3012907473 |
| Address | 3790 Arapaho Rd |
| City | Addison |
| State | TX |
| ZIP | 75001 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | May 27, 2021 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 624782 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data